• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主对微寄生物的三种抗性机制——避免感染、恢复和耐受——呈现出不同的进化动态。

Three mechanisms of host resistance to microparasites-avoidance, recovery and tolerance-show different evolutionary dynamics.

作者信息

Boots M, Bowers R G

机构信息

Department of Biology, Kyushu University, Higashi-ku, Fukuoka, 812-81, Japan.

出版信息

J Theor Biol. 1999 Nov 7;201(1):13-23. doi: 10.1006/jtbi.1999.1009.

DOI:10.1006/jtbi.1999.1009
PMID:10534432
Abstract

Parasite resistant hosts may avoid becoming infected, recover more quickly after infection or survive longer once infected. A model is constructed to examine the evolution of costly host resistance to directly transmitted microparasites and these three distinct mechanisms of avoidance, recovery and tolerance are compared. In each case polymorphism is more likely between very dissimilar strains and resistance (by which we mean the resistant strain alone) is always more likely to occur in hosts with high intrinsic productivity. However, the region where polymorphism occurs is relatively much smaller when resistance is through reduced pathogenicity. In particular, polymorphism with highly resistant strains requires correspondingly high costs. This is in contrast to avoidance or recovery resistance, where polymorphism can also occur when high resistance is associated with small costs due to the inability of highly resistant strains with low susceptibility or high recovery to support the parasite alone and hence resist invasion by the susceptible strain. Relatedly, resistance through avoidance and recovery is favoured in response to less pathogenic parasites.

摘要

具有抗寄生虫能力的宿主可能会避免被感染,感染后恢复得更快,或者一旦被感染就能存活更长时间。构建了一个模型来研究宿主对直接传播的微寄生虫产生高成本抗性的进化过程,并比较了避免感染、恢复和耐受这三种不同机制。在每种情况下,多态性在非常不同的菌株之间更有可能出现,并且抗性(我们指的是单独的抗性菌株)总是更有可能出现在具有高内在生产力的宿主中。然而,当抗性是通过降低致病性实现时,多态性出现的区域相对要小得多。特别是,与高抗性菌株的多态性需要相应的高成本。这与避免感染或恢复抗性形成对比,在避免感染或恢复抗性中,当高抗性与低成本相关时也会出现多态性,这是因为低易感性或高恢复能力的高抗性菌株无法单独支持寄生虫,从而抵抗易感菌株的入侵。相关地,针对致病性较低的寄生虫,通过避免感染和恢复产生的抗性更受青睐。

相似文献

1
Three mechanisms of host resistance to microparasites-avoidance, recovery and tolerance-show different evolutionary dynamics.宿主对微寄生物的三种抗性机制——避免感染、恢复和耐受——呈现出不同的进化动态。
J Theor Biol. 1999 Nov 7;201(1):13-23. doi: 10.1006/jtbi.1999.1009.
2
The evolution of host resistance: tolerance and control as distinct strategies.宿主抗性的演变:耐受与控制作为不同的策略。
J Theor Biol. 2005 Sep 21;236(2):198-207. doi: 10.1016/j.jtbi.2005.03.005. Epub 2005 Apr 18.
3
Host life span and the evolution of resistance characteristics.宿主寿命与抗性特征的进化
Evolution. 2007 Jan;61(1):2-14. doi: 10.1111/j.1558-5646.2007.00001.x.
4
The evolution of resistance through costly acquired immunity.通过代价高昂的获得性免疫产生抗性的进化过程。
Proc Biol Sci. 2004 Apr 7;271(1540):715-23. doi: 10.1098/rspb.2003.2655.
5
Vaccination, within-host dynamics, and virulence evolution.疫苗接种、宿主体内动态变化与毒力进化
Evolution. 2006 Jan;60(1):13-23.
6
The population dynamics of microparasites and vertebrate hosts: the importance of immunity and recovery.微寄生虫与脊椎动物宿主的种群动态:免疫与恢复的重要性
Theor Popul Biol. 1994 Aug;46(1):96-119. doi: 10.1006/tpbi.1994.1021.
7
Lethal pathogens, non-lethal synergists and the evolutionary ecology of resistance.致死性病原体、非致死性增效剂与抗性的进化生态学
J Theor Biol. 2008 Sep 21;254(2):339-49. doi: 10.1016/j.jtbi.2008.05.036. Epub 2008 Jun 1.
8
Ecological feedbacks and the evolution of resistance.生态反馈与抗药性的进化。
J Anim Ecol. 2009 Nov;78(6):1106-12. doi: 10.1111/j.1365-2656.2009.01568.x. Epub 2009 May 28.
9
The evolution of host-parasite range.宿主-寄生虫范围的演变。
Am Nat. 2010 Jul;176(1):63-71. doi: 10.1086/653002.
10
A baseline model for the apparent competition between many host strains: the evolution of host resistance to microparasites.许多宿主菌株间表观竞争的基线模型:宿主对微寄生物抗性的进化
J Theor Biol. 1999 Sep 7;200(1):65-75. doi: 10.1006/jtbi.1999.0976.

引用本文的文献

1
Predicting the evolutionary and epidemiological dynamics of SARS-CoV-2 in South Africa.预测南非新冠病毒的进化和流行病学动态。
Virulence. 2025 Dec;16(1):2520335. doi: 10.1080/21505594.2025.2520335. Epub 2025 Aug 3.
2
Warming During Different Life Stages has Distinct Impacts on Host Resistance Ecology and Evolution.不同生命阶段的升温对宿主抗性生态和进化有不同影响。
Ecol Lett. 2025 Feb;28(2):e70087. doi: 10.1111/ele.70087.
3
Avoiding the tragedies of parasite tolerance in Darwinian beekeeping.避免达尔文式养蜂中寄生虫耐受性的悲剧。
Proc Biol Sci. 2025 Feb;292(2040):20242433. doi: 10.1098/rspb.2024.2433. Epub 2025 Feb 5.
4
Taking cues from ecological and evolutionary theories to expand the landscape of disgust.借鉴生态与进化理论以拓展厌恶情绪的范畴。
Proc Biol Sci. 2024 Dec;291(2036):20241919. doi: 10.1098/rspb.2024.1919. Epub 2024 Dec 4.
5
Microbial genetic variation impacts host eco-immunological strategies and microparasite fitness in Lyme borreliae-reptile system.微生物遗传变异影响莱姆疏螺旋体-爬行动物系统中的宿主生态免疫策略和微寄生虫适应性。
Ticks Tick Borne Dis. 2024 Nov;15(6):102410. doi: 10.1016/j.ttbdis.2024.102410. Epub 2024 Nov 14.
6
Body Size of Female Strepsipteran Parasites (Strepsiptera, Xenidae, ) Depends on Several Key Factors in a Vespine Wasp (Hymenoptera, Vespidae, ).雌性捻翅目寄生虫(捻翅目,异腹捻翅科)的体型大小取决于胡蜂(膜翅目,胡蜂科)中的几个关键因素。
Insects. 2024 Apr 12;15(4):266. doi: 10.3390/insects15040266.
7
Coevolution of Age-Structured Tolerance and Virulence.年龄结构耐受性与毒力的协同进化
Bull Math Biol. 2024 Apr 25;86(6):62. doi: 10.1007/s11538-024-01292-2.
8
A Palearctic view of a bat fungal disease.蝙蝠真菌病的古北区视角。
Conserv Biol. 2025 Feb;39(1):e14265. doi: 10.1111/cobi.14265. Epub 2024 Apr 15.
9
The impact of sterility-mortality tolerance and recovery-transmission trade-offs on host-parasite coevolution.无菌-致死权衡和恢复-传播权衡对宿主-寄生虫共进化的影响。
Proc Biol Sci. 2024 Feb 28;291(2017):20232610. doi: 10.1098/rspb.2023.2610. Epub 2024 Feb 21.
10
Varying conjunctival immune response adaptations of house finch populations to a rapidly evolving bacterial pathogen.雀形目鸟类对快速进化的细菌病原体的结膜免疫反应适应性存在差异。
Front Immunol. 2024 Feb 2;15:1250818. doi: 10.3389/fimmu.2024.1250818. eCollection 2024.